Gene Expression Nebulas
A data portal of transcriptomic profiles analyzed by a unified pipeline across multiple species

Gene Expression Nebulas

A data portal of transcriptome profiles across multiple species

PRJNA285793: Single-cell RNA sequencing of lung adenocarcinoma patient-derived cells

Source: NCBI / GSE69405
Submission Date: Jun 03 2015
Release Date: Jun 03 2015
Update Date: May 15 2019

Summary: To address how intratumoral heterogeneity affects anti-cancer drug responses; we profiled transcriptomes of single cancer cells originating from lung adenocarcinoma patient-derived xenograft (PDX) tumors.

Overall Design: We performed single-cell RNA sequencing (scRNA-Seq) together with bulk sequencing by applying Smart-Seq protocol (Ramsk ld et al.; Nat Biotechnol 2012). Enrichment of cancer cells in PDX from primary tumor (LC-PT-45: bulk RNA-Seq; n=1) was identified by histopathological examination and genomic signatures. Tumor cell-enriched PDX cells (LC-PT-45: scRNA-Seq; n=34; bulk RNA-Seq; n=9) were analyzed; and additional batch (LC-Pt-45-Re: scRNA-Seq; n=43; bulk RNA-Seq; n=7) was obtained to check comparable results. H358 human lung cancer cells (scRNA-Seq; n=50; bulk RNA-Seq; n=1) were used as cell line controls. Another lung cancer PDX case (LC-MBT-15: scRNA-Seq; n=49; bulk RNA-Seq; n=7) was prepared to validate our analytical strategy applied in the LC-PT-45 case.

GEN Datasets:
GEND000194 GEND000195
Strategy:
Species:
Tissue:
Healthy Condition:
Cell Type:
Cell Line:
Protocol
Growth Protocol: Animal experiments were conducted in accordance with the Institute for Laboratory Animal Research Guide for the Care and Use of Laboratory Animals and within the protocols approved by the appropriate IRB at the Samsung Medical Center. Xenograft tumor specimens were dissociated into single cell. Dissociated cell were cultured in neurobasal media-A supplemented with N2 (脳1/2); B27 (脳1/2) (GIBCO; Carlsbad; CA); bFGF/EGF (25ng/ml each); neuregulin 1 (hNRG1; 10ng/ml); and long-insulin growth factor 1 (IGF1; 100ng/ml) (R&D Systems; Minneapolis; MN). As spheres appeared in suspension culture conditions; they were dissociated with accutase (PAA Laboratories GmbH; C枚lbe; Germany) and expanded by reseeding.; Animal experiments were conducted in accordance with the Institute for Laboratory Animal Research Guide for the Care and Use of Laboratory Animals and within the protocols approved by the appropriate IRB at the Samsung Medical Center. Xenograft tumor specimens were dissociated into single cells. Dissociated cells were cultured in neurobasal media-A supplemented with N2 (脳1/2); B27 (脳1/2) (GIBCO; Carlsbad; CA); bFGF/EGF (25ng/ml each); neuregulin 1 (hNRG1; 10ng/ml); and long-insulin growth factor 1 (IGF1; 100ng/ml) (R&D Systems; Minneapolis; MN). As spheres appeared in suspension culture conditions; they were dissociated with accutase (PAA Laboratories GmbH; C枚lbe; Germany) and expanded by reseeding.; Animal experiments were conducted in accordance with the Institute for Laboratory Animal Research Guide for the Care and Use of Laboratory Animals and within the protocols approved by the appropriate IRB at the Samsung Medical Center. Xenograft tumor specimens were dissociated into single cells. Dissociated cells were cultured in neurobasal media-A supplemented with N2 (×1/2), B27 (×1/2) (GIBCO, Carlsbad, CA), bFGF/EGF (25ng/ml each), neuregulin 1 (hNRG1, 10ng/ml), and long-insulin growth factor 1 (IGF1, 100ng/ml) (R&D Systems, Minneapolis, MN). As spheres appeared in suspension culture conditions, they were dissociated with accutase (PAA Laboratories GmbH, Cölbe, Germany) and expanded by reseeding.
Treatment Protocol: For drug screening, PDX cell in the serum free sphere culture condition were seeded in 384-well plates (500 cell/well). Two hours after plating, cell were treated with a drug library (Selleck, Houston, TX) in 3 folds and 10 points serial dilution (n=3 for each condition). After 6 days incubation at 37°C in a 5% CO2 humidified incubator, cell viability was analyzed using an ATP monitoring system based on firefly luciferase (ATPliteTM 1step, PerkinElmer, Waltham, CA). Test concentrations for each drug have been derived empirically to produce a clinically relevant spectrum of drug activity. Dose response curves and corresponding half maximal (50%) inhibitory concentration values (IC50) were calculated using the S+ Chip Analyzer (Samsung Electro-Mechanics, Suwon, Korea).; -
Extract Protocol: RNAs from bulk cell samples were also amplified using a SMARTer kit with 10 ng of starting material. For WES, gDNAs were prepared using QIAamp® DNA Mini kit (QIAGEN, CA, USA).; In order to isolate single-cells and amplify initial RNA content enough to transcriptome sequencing, we adopted the C1TM Single-Cell Auto Prep System (Fluidigm, CA, USA) with the SMARTer kit (Clontech, CA, USA). Cells were captured on the C1 chip (17-25 μm) and determined as a live single cell by fluorescence microscopic observation. Quantity and quality of amplified cDNAs from individual single cells were checked by Qubit 2.0 Fluorometer (Life Technologies, CA, USA) and 2100 Bioanalyzer (Agilent Inc., CA, USA). RNAs from bulk cell samples were also amplified using a SMARTer kit with 10 ng of starting material. For WES, gDNAs were prepared using QIAamp DNA Mini kit (QIAGEN, CA, USA). Exome sequencing was carried using the SureSelect XT Human All Exon V5 kit (Agilent Inc., CA, USA), according to the manufacturer’s standard protocol.
Library Construction Protocol: Libraries were prepared using the Nextera XT DNA Sample Prep Kit (Illumina, CA, USA) following the manufacturer’s instruction, assayed the quantity and quality, pooled, and then sequenced on the HiSeq 2500 (Illumina) using the 100bp paired-end mode of the TruSeq Rapid PE Cluster kit and TruSeq Rapid SBS kit (Illumina) at the Samsung Genome Institute (Seoul, Korea). ?Sequencing of the exome library was carried out on the HiSeq 2500 (Illumina, CA, USA) using the 100bp paired-end mode of the TruSeq Rapid PE Cluster kit and TruSeq Rapid SBS kit (Illumina) at the Samsung Genome Institute (Seoul, Korea).?; Libraries were prepared using the Nextera XT DNA Sample Prep Kit (Illumina, CA, USA) following the manufacturer’s instruction, assayed the quantity and quality, pooled, and then sequenced on the HiSeq 2500 (Illumina) using the 100bp paired-end mode of the TruSeq Rapid PE Cluster kit and TruSeq Rapid SBS kit (Illumina) at the Samsung Genome Institute (Seoul, Korea). Sequencing of the exome library was carried out on the HiSeq 2500 (Illumina, CA, USA) using the 100bp paired-end mode of the TruSeq Rapid PE Cluster kit and TruSeq Rapid SBS kit (Illumina) at the Samsung Genome Institute (Seoul, Korea).
Sequencing
Molecule Type: poly(A)+ RNA
Library Source:
Library Layout: PAIRED
Library Strand: -
Platform: ILLUMINA
Instrument Model: Illumina HiSeq 2500
Strand-Specific: Unspecific
Samples
Basic Information:
Sample Characteristic:
Biological Condition:
Experimental Variables:
Protocol:
Sequencing:
Assessing Quality:
Analysis:
Data Resource GEN Sample ID GEN Dataset ID Project ID BioProject ID Sample ID Sample Name BioSample ID Sample Accession Experiment Accession Release Date Submission Date Update Date Species Race Ethnicity Age Age Unit Gender Source Name Tissue Cell Type Cell Subtype Cell Line Disease Disease State Development Stage Mutation Phenotype Case Detail Control Detail Growth Protocol Treatment Protocol Extract Protocol Library Construction Protocol Molecule Type Library Layout Strand-Specific Library Strand Spike-In Strategy Platform Instrument Model Cell Number Reads Number Gbases AvgSpotLen1 AvgSpotLen2 Uniq Mapping Rate Multiple Mapping Rate Coverage Rate
Publications
Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.
Genome biology . 2015-06-19 [PMID: 26084335]